Inventor · disambiguated record
Anjali Pandey
Also filed as: PANDEY ANJALI · SCARBOROUGH LEGAL REPRESENTATIVE CARROLL
94 granted patents·59 pending applications·534 citations·filing 1992–2025
99Inventor score
Files withPORTOLA PHARM INC38MILLENNIUM PHARM INC18MAJEED MUHAMMED16SRX CARDIO LLC11SUDO BIOSCIENCES LTD9
Top patents by PatentIndex Score
153 records- 0197US8138339B2Inhibitors of protein kinasesBAUER SHAWN M·Filed 2009·Granted Mar 20, 2012·63 cites·19 claims
- 0295US10980801B2Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their useSRX CARDIO LLC·Filed 2020·Granted Apr 20, 2021·6 cites·15 claims
- 0395US8258144B2Inhibitors of protein kinasesSONG YONGHONG·Filed 2009·Granted Sep 4, 2012·37 cites·19 claims
- 0494US8937070B2Inhibitors of protein kinasesPORTOLA PHARM INC·Filed 2013·Granted Jan 20, 2015·16 cites·7 claims
- 0594US8501944B2Inhibitors of protein kinasesBAUER SHAWN M·Filed 2012·Granted Aug 6, 2013·19 cites·2 claims
- 0694US8349860B2Inhibitors of syk and JAK protein kinasesPORTOLA PHARM INC·Filed 2011·Granted Jan 8, 2013·9 cites·2 claims
- 0794US8318755B2Inhibitors of SYK and JAK protein kinasesJIA ZHAOZHONG J·Filed 2011·Granted Nov 27, 2012·10 cites·2 claims
- 0894US8063058B2Inhibitors of syk and JAK protein kinasesJIA ZHAOZHONG J·Filed 2009·Granted Nov 22, 2011·14 cites·17 claims
- 0994US7361669B2Compositions and method for inhibiting TGF-βMILLENNIUM PHARM INC·Filed 2003·Granted Apr 22, 2008·43 cites·7 claims
- 1093US7767697B2Factor Xa inhibitorsMILLENNIUM PHARM INC·Filed 2008·Granted Aug 3, 2010·17 cites·11 claims
- 1192US11613548B2Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inhibitorsSUDO BIOSCIENCES LTD·Filed 2022·Granted Mar 28, 2023·3 cites·21 claims
- 1292US10865185B2Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activitySRX CARDIO LLC·Filed 2016·Granted Dec 15, 2020·5 cites·8 claims
- 1392US10568882B2Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their useSRX CARDIO LLC·Filed 2016·Granted Feb 25, 2020·6 cites·13 claims
- 1492US9868729B2Inhibitors of protein kinasesPORTOLA PHARM INC·Filed 2014·Granted Jan 16, 2018·12 cites·12 claims
- 1592US8952027B2Inhibitors of syk and JAK protein kinasesPORTOLA PHARM INC·Filed 2012·Granted Feb 10, 2015·6 cites·21 claims
- 1692US8853230B2Inhibitors of JAKPORTOLA PHARM INC·Filed 2012·Granted Oct 7, 2014·19 cites·14 claims
- 1792US7763608B2Factor Xa inhibitorsMILLENNIUM PHARM INC·Filed 2007·Granted Jul 27, 2010·16 cites·8 claims
- 1892US7705004B2Protein kinase inhibitorsPORTOLA PHARM INC·Filed 2008·Granted Apr 27, 2010·22 cites·17 claims
- 1992US7049297B2Indazole peptidomimetics as thrombin receptor antagonistsORTHO MCNEIL PHARM INC·Filed 2003·Granted May 23, 2006·26 cites·2 claims
- 2090US11040964B2Compounds and methods of useFERRO THERAPEUTICS INC·Filed 2020·Granted Jun 22, 2021·4 cites·30 claims
- 2189US12103937B2Substituted pyridines and pyridazines as TYK2 inhibitorsSUDO BIOSCIENCES LTD·Filed 2023·Granted Oct 1, 2024·1 cites·21 claims
- 2289US12084458B2Substituted pyridines, pyridazines, and pyrimidines as TYK2 inhibitorsSUDO BIOSCIENCES LTD·Filed 2023·Granted Sep 10, 2024·1 cites·21 claims
- 2389US10821106B2Composition and methods of use of novel phenylalanine small organic compounds to directly modulate PCSK9 protein activitySRX CARDIO LLC·Filed 2016·Granted Nov 3, 2020·4 cites·11 claims
- 2488US12122785B2Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inhibitorsSUDO BIOSCIENCES LTD·Filed 2023·Granted Oct 22, 2024·1 cites·20 claims
- 2588US10533001B2Inhibitors of protein kinasesPORTOLA PHARM INC·Filed 2017·Granted Jan 14, 2020·4 cites·13 claims
- 2688US8367689B2Inhibitors of JAKPORTOLA PHARM INC·Filed 2010·Granted Feb 5, 2013·11 cites·27 claims
- 2788US7943640B2Compositions and methods for inhibiting TGF-βMILLENIUM PHARMACEUTICALS INC·Filed 2007·Granted May 17, 2011·5 cites·23 claims
- 2887US12350269B2Cerdulatinib for the treatment of b-cell malignanciesALEXION PHARMA INC·Filed 2021·Granted Jul 8, 2025·1 cites·10 claims
- 2987US8877760B2Substituted pyrazine-2-carboxamide kinase inhibitorsPORTOLA PHARM INC·Filed 2012·Granted Nov 4, 2014·8 cites·5 claims
- 3086US7189733B2Compositions and methods for inhibiting TGF-βMILLENNIUM PHARM INC·Filed 2004·Granted Mar 13, 2007·21 cites·7 claims
- 3185US8268857B2Compositions and methods for inhibiting TGF-βSCARBOROUGH ROBERT M·Filed 2007·Granted Sep 18, 2012·8 cites·5 claims
- 3285US7834023B2Substituted dihydroquinazolines as platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2007·Granted Nov 16, 2010·4 cites·26 claims
- 3384US8846928B2Benzamides and nicotinamides as Syk modulatorsJIA ZHAOZHONG J·Filed 2011·Granted Sep 30, 2014·7 cites·26 claims
- 3483US10172903B2Composition comprising scirpusin A and scirpusin B and anti-obesity potential thereofMAJEED MUHAMMED·Filed 2016·Granted Jan 8, 2019·2 cites·2 claims
- 3583US9676756B2Substituted pyrimidinyl kinase inhibitorsPORTOLA PHARM INC·Filed 2013·Granted Jun 13, 2017·6 cites·23 claims
- 3683US9359375B2Benzamides and nicotinamides as Syk modulatorsPORTOLA PHARM INC·Filed 2014·Granted Jun 7, 2016·5 cites·15 claims
- 3783US8063077B2Factor Xa inhibitorsSONG YONGHONG·Filed 2010·Granted Nov 22, 2011·6 cites·10 claims
- 3883US6982266B2Quinazoline derivatives as kinase inhibitorsKYOWA HAKKO KOGYO KK·Filed 2001·Granted Jan 3, 2006·12 cites·11 claims
- 3982US8933121B2Anti-obesity potential of Calebin AMAJEED MUHAMMED·Filed 2012·Granted Jan 13, 2015·2 cites·12 claims
- 4082US7314939B2Compositions and methods for inhibiting TGF-βMILLENNIUM PHARM INC·Filed 2004·Granted Jan 1, 2008·14 cites·22 claims
- 4181US11052125B2Compositions for weight lossMAJEED MUHAMMED·Filed 2019·Granted Jul 6, 2021·1 cites·8 claims
- 4281US9102625B2Nicotinamides as JAK kinase modulatorsBAUER SHAWN M·Filed 2011·Granted Aug 11, 2015·5 cites·10 claims
- 4381US2024383916A1Substituted pyridines, pyridazines, and pyrimidines as tyk2 inhibitorsSUDO BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 4481US2024391934A1Substituted pyridines and pyridazines as tyk2 inhibitorsSUDO BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 4580US2024415830A1Composition and methods of use of novel phenylalanine small organic compounds to directly modulate pcsk9 protein activitySRX CARDIO LLC·Filed 2024·Application pending·0 cites
- 4679US11414410B2Inhibitors of protein kinasesALEXION PHARMA INC·Filed 2019·Granted Aug 16, 2022·0 cites·6 claims
- 4779US7709640B2Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereofMILLENNIUM PHARM INC·Filed 2005·Granted May 4, 2010·2 cites·2 claims
- 4878US2025011335A1Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as tyk2 inhibitorsSUDO BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 4976US9533986B2Bicyclic dihydropyridone kinase inhibitorsPORTOLA PHARM INC·Filed 2013·Granted Jan 3, 2017·3 cites·18 claims
- 5076US9469654B2Bicyclic oxa-lactam kinase inhibitorsPORTOLA PHARM INC·Filed 2013·Granted Oct 18, 2016·3 cites·20 claims
Showing the top 50 of 153 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Anjali Pandey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →